Yajuan Wang is joining Beijing Sunrise Biotech Co, a wholly-owned subsidiary of Sunrise Biotech, as general manager.
Wang - who bought a 10.01% stake in Sunrise Biotech in January - will have specific responsibility for operations and finance.
Sunrise Biotech chairman and chief executive Yonghu Li said: "Ms Wang has invaluable experience of Chinese state-owned companies and has strong connections with senior government officials and members of the investment community.
"She will add significantly to the development of the company."
Founded in January 2005, Beijing Sunrise develops and produces mulberry based products from three locations in the Yongledian Region of Beijing.
Story provided by Business Financial Newswire